XML 44 R26.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Goodwill and Intangible Assets (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract] |
Summary of intangible assets by major asset class | The following sets forth the goodwill and intangible assets by major asset class:
|  |  | September 30, 2016 |  | December 31, 2015
| Useful Life (Yrs) | Gross |  | Accumulated Amortization |  | Net Book Value |  | Gross |  | Accumulated Amortization |  | Net Book Value
Non-Amortizing: |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill(a) |  |  | $ | 10,513,371 |  |  | $ | — |  |  | $ | 10,513,371 |  |  | $ | 10,113,371 |  |  | $ | — |  |  | $ | 10,113,371 |
Amortizing: |  |  |  |  |  |  |  |  |  |  |  |  |
Patents | 8 – 17 |  | 5,802,528 |  |  | (5,599,335 | ) |  | 203,193 |  |  | 5,802,528 |  |  | (5,516,122 | ) |  | 286,406 |
Licenses | 8 – 17 |  | 1,323,761 |  |  | (1,154,674 | ) |  | 169,087 |  |  | 1,323,761 |  |  | (1,133,113 | ) |  | 190,648 |
CELLECTRA®(b) | 5 – 11 |  | 8,106,270 |  |  | (6,718,257 | ) |  | 1,388,013 |  |  | 8,106,270 |  |  | (6,397,947 | ) |  | 1,708,323 |
GHRH(b) | 11 |  | 335,314 |  |  | (232,344 | ) |  | 102,970 |  |  | 335,314 |  |  | (208,581 | ) |  | 126,733 |
Bioject (c) | 2 – 15 |  | 5,100,000 |  |  | (351,389 | ) |  | 4,748,611 |  |  | — |  | — |  | — |  |  | — |
Other(d) | 18 |  | 4,050,000 |  |  | (2,625,000 | ) |  | 1,425,000 |  |  | 4,050,000 |  |  | (2,456,250 | ) |  | 1,593,750 |
Total intangible assets |  |  | 24,717,873 |  |  | (16,680,999 | ) |  | 8,036,874 |  |  | 19,617,873 |  |  | (15,712,013 | ) |  | 3,905,860 |
Total goodwill and intangible assets |  |  | $ | 35,231,244 |  |  | $ | (16,680,999 | ) |  | $ | 18,550,245 |  |  | $ | 29,731,244 |  |  | $ | (15,712,013 | ) |  | $ | 14,019,231 |
(a) | Goodwill was recorded from the Inovio AS acquisition in January 2005, the acquisition of VGX in June 2009 and the acquisition of Bioject in April 2016 for $3.9 million, $6.2 million and $400,000, respectively.
(b) | CELLECTRA® and GHRH are developed technologies which were recorded from the acquisition of VGX.
(c) | Bioject intangible assets represent the fair value of developed technology and intellectual property which were recorded from the acquisition of Bioject.
(d) | Other intangible assets represent the fair value of acquired intellectual property from the Inovio AS acquisition.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration